The University of Milano-Bicocca, located in Milan, Italy, has recently received a new 7T MRI system from Mediso, a leading medical imaging company. This state-of-the-art system will allow researchers and clinicians at the university to conduct advanced imaging studies with unprecedented detail and accuracy.
Magnetic resonance imaging (MRI) is a non-invasive medical imaging technique that uses strong magnetic fields and radio waves to produce detailed images of the body’s internal structures. MRI is widely used in clinical medicine for the diagnosis and monitoring of a wide range of conditions, including cancer, neurological disorders, and musculoskeletal injuries.
The new 7T MRI system from Mediso is a significant upgrade over the university’s previous imaging equipment. The system operates at a magnetic field strength of 7 Tesla, which is more than twice as powerful as the standard 3T MRI systems commonly used in clinical practice. This increased field strength allows for higher resolution images with greater contrast and sensitivity, making it possible to detect even subtle changes in tissue structure and function.
The new system also features advanced imaging techniques such as diffusion tensor imaging (DTI) and functional MRI (fMRI), which can provide detailed information about the brain’s white matter tracts and functional connectivity. These techniques are particularly useful for studying neurological disorders such as Alzheimer’s disease, multiple sclerosis, and traumatic brain injury.
In addition to its research applications, the new 7T MRI system will also be used for clinical imaging studies at the university’s affiliated hospitals. The system’s high resolution and sensitivity will enable clinicians to more accurately diagnose and monitor a wide range of conditions, leading to better patient outcomes.
The acquisition of this new 7T MRI system represents a significant investment in the University of Milano-Bicocca’s research and clinical capabilities. With its advanced imaging capabilities, the system will enable researchers and clinicians to conduct cutting-edge studies that could lead to new insights into the mechanisms of disease and new treatments for a wide range of conditions.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- Buy and Sell Shares in PRE-IPO Companies with PREIPO®. Access Here.
- PlatoAiStream. Web3 Data Intelligence. Knowledge Amplified. Access Here.
- Source: Plato Data Intelligence.
An Overview of the FDA’s Draft Guidance on Translation of GLP Study Reports in the United States
An Overview of the FDA’s Draft Guidance on Translation of GLP Study Reports in the United States The Food and...